Nav: Home

Atherosclerosis: Induced cell death destabilizes plaques

May 01, 2019

At LMU's Institute for Cardiovascular Prevention, Oliver Söhnlein investigates the molecular mechanisms that underlie chronic inflammatory disorders, including atherosclerosis. These conditions are largely due to unresolved innate immune responses. In a collaborative study carried out by an international team of researchers, which appears in the journal Nature, he and his colleagues focus on the role of cells known as neutrophils, which form a large part of the innate immune system. "Every inflammatory reaction results in some collateral damage, because neutrophils also attack healthy cells," he explains. The new report describes how neutrophils damage tissues by initiating a previously unrecognized type of induced cell death. Söhnlein's group has also developed a synthetic peptide that inhibits this deleterious process.

Atherosclerosis is characterized by the build-up of fat-rich deposits known as plaques under the endothelial cell layer that forms the blood-vessel wall. Immune cells migrate to sites of plaque formation via the bloodstream in response to specific biochemical signals. They enter the underlying tissue by infiltrating between endothelial cells, while releasing compounds that attract still more immune cells, until at some point the inflammatory reaction becomes chronic. Chronic inflammation increases the probability that continuing plaque growth will lead to rupture of the lesion. Once this happens, the plaque can induce clotting and obstruct blood flow, and may precipitate a heart attack or a stroke. Neutrophils can play an especially pernicious role in the destabilization of plaques. "They bind to the smooth muscle cells that underlie the vessel wall, and are activated. Activation results in the release of chromosomal DNA and its associated histones, which are highly charged and cytotoxic. Free histones kill nearby cells - in the case of atherosclerosis, smooth muscle cells," Söhnlein says. Histones cause the death of these cells by inducing the formation of pores in their membranes. This allows extracellular fluids to pour into the cells and causes them to burst. Loss of these cells in turn destabilizes plaques, as the latter are no longer supported by underlying smooth muscle cells.

Based on molecular modeling, Söhnlein and his group have designed and synthesized a peptide that binds to free histones and neutralizes their toxic effect. Thanks to its mode of action, the peptide should have the same effect on other disorders that are associated with chronic inflammation, such as arthritis and chronic bowel inflammation, says Söhnlein. A patent application has already been submitted.

Ludwig-Maximilians-Universität München

Related Atherosclerosis Articles:

Atherosclerosis progresses rapidly in healthy people from the age of 40
A CNIC study published in JACC demonstrates that atheroma plaques extend rapidly in the arteries of asymptomatic individuals aged between 40 and 50 years participating in the PESA-CNIC-Santander study.
Discovery may illuminate a missing link between atherosclerosis and aging
Using a preclinical model of atherosclerosis, Feinberg and colleagues have uncovered a long, noncoding RNA (lncRNA) that may point the way toward new therapies for atherosclerosis and shed light on why the likelihood of the disease increases with age.
Scaling up a nanoimmunotherapy for atherosclerosis through preclinical testing
By integrating translational imaging techniques with improvements to production methods, Tina Binderup and colleagues have scaled up a promising nanoimmunotherapy for atherosclerosis in mice, rabbits and pigs -- surmounting a major obstacle in nanomedicine.
Bladder drug linked to atherosclerosis in mice
A drug used in the treatment of overactive bladder can accelerate atheroclerosis in mice, researchers at Karolinska Institutet in Sweden report in a study published in the Proceedings of the National Academy of Sciences (PNAS).
Atherosclerosis: Induced cell death destabilizes plaques
Many chronic disorders arise from misdirected immune responses. A Ludwig-Maximilians-Universitaet (LMU) in Munich team led by Oliver Söhnlein now shows that neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death and that a tailored peptide inhibits the process.
A new therapeutic target for blocking early atherosclerosis in progeria
Researchers at the Centro Nacional de Investigaciones Cardiovasculares and the Universidad de Oviedo have discovered a new molecular mechanism involved in the premature development of atherosclerosis in mice with Hutchinson-Gilford progeria syndrome.
Protective mechanism against atherosclerosis discovered
Immune cells promoting inflammation play a crucial role in the development of atherosclerosis.
Atherosclerosis: Stopped on time
For the first time, LMU researchers are pointing out the influence of the internal clock on atherosclerosis.
New actors identified in atherosclerosis
Stroke and heart attack are the leading cause of death in the Western world.
Running multiple marathons does not increase risk of atherosclerosis
Running multiple marathons does not increase the risk of atherosclerosis, according to research published today in the European Journal of Preventive Cardiology.
More Atherosclerosis News and Atherosclerosis Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at